BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Hesperos Inc. - ECPv6.15.18//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Hesperos Inc.
X-ORIGINAL-URL:https://hesperosinc.com
X-WR-CALDESC:Events for Hesperos Inc.
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20230101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260408
DTEND;VALUE=DATE:20260409
DTSTAMP:20260409T103734
CREATED:20260403T171458Z
LAST-MODIFIED:20260403T171546Z
UID:3654-1775606400-1775692799@hesperosinc.com
SUMMARY:Hesperos Chief Scientist Presenting at Quantitative Systems Pharmacology Conference 2026​​​​​​​​​​​​​​​​​​
DESCRIPTION:Details:\nDate: 08 April 2026\nTime:  16:10 (UTC+2)\nSession 4: Integrating Micro-Physiological and Organ-on-Chip Systems with QSP \nHesperos\, Inc. is proud to announce that our Chief Scientist\, Dr. James J. Hickman\, will be a featured speaker at the upcoming Quantitative Systems Pharmacology Conference (QSPC) 2026 in Leiden\, Netherlands. This event brings together global leaders from academia\, industry\, and regulatory agencies to explore advances in quantitative systems pharmacology (QSP) and mechanism-based pharmacokinetics and pharmacodynamics (PK/PD).  \nPresentation:\n“Regulatory Acceptance of Microphysiological and Organ-on-Chip Systems”\nAs the drug discovery landscape shifts toward more human-relevant models\, the integration of microphysiological systems (such as our Human-on-a-Chip® single- and multi-organ system models) with QSP is becoming a critical bridge for translational success. In this talk\, Dr. Hickman will discuss the path toward regulatory acceptance for these platforms. \nSession 4 explores the synergy between organ-on-a-chip platforms and the mathematical frameworks of QSP including PK/PD. Among other topics\, attendees will gain a deeper understanding of: \n\nThe current status of MPS validation for regulatory use.\nHow Hesperos’ serum-free\, single and multi-organ platforms can be combined with QSP models.\nStrategies for utilizing human-relevant data to better inform and accelerate clinical development timelines.\n\nAbout the Speaker\nJames J. Hickman\, Ph.D.\, is the Chief Scientist and Co-Founder of Hesperos\, Inc. He is also the Founding Director of the NanoScience Technology Center at the University of Central Florida. A pioneer in the field\, Dr. Hickman has spent over 30 years developing functional in vitro systems. He is a Fellow of the American Institute for Medical and Biological Engineering (AIMBE)\, the National Academy of Inventors\, and is the President of the International Microphysiological Systems Society (IMPSS). \n\nPlanning to attend QSPC 2026? We invite you to connect with Dr. Hickman to discuss how our Human-on-a-Chip® technology can support your drug development programs. \nLink to Registration and Full Program
URL:https://hesperosinc.com/event/hesperos-chief-scientist-presenting-at-quantitative-systems-pharmacology-conference-2026/
LOCATION:Stadsgehoorzaal\, Breestraat 60\, 2311 CS\, Leiden\, Leiden\, Netherlands
CATEGORIES:Invited Speaker
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/04/JH-Talk-QSPC-2026.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260322
DTEND;VALUE=DATE:20260326
DTSTAMP:20260409T103734
CREATED:20260304T195539Z
LAST-MODIFIED:20260320T144307Z
UID:3539-1774137600-1774483199@hesperosinc.com
SUMMARY:Join Hesperos at Society of Toxicology (SOT) 2026: Booth #846
DESCRIPTION:Visit Hesperos at SOT 2026 ToxExpo: Booth #846\nStop by and take the opportunity to discuss how Hesperos’ single and multi-organ Human-on-a-Chip® organ system models can help your organization better elucidate and understand your product’s profile. \n\nFeatured Presentations\n \n\nPoster Presentation: \n#H624: The Utilization of In Vitro\, Human on a Chip Cortical Networks to Assess Neurocognitive Impairment for Drug Safety and Efficacy \n\nPresented by: Rocky Brighton\nTuesday\, March 24\, 9:15am – 11:45am PT\nView Session Details\n\n\nPoster Presentation: \n#F505: Off target toxicity and efficacy testing of a novel stress reliever in a multi-organ microphysiological system \n\nPresented by: Christopher McAleer\, PhD\nWednesday\, March 25\, 9:15am – 11:45am PT\nView Session Details\n\n\n\n\n  \nView Hesperos SOT Booth #846
URL:https://hesperosinc.com/event/hesperos-at-sot-2026-booth-846/
LOCATION:San Diego Convention Center
CATEGORIES:Exhibitor,Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/03/SOT-Announcement-Graphic1200-x-700-px.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260205T110000
DTEND;TZID=UTC:20260205T120000
DTSTAMP:20260409T103734
CREATED:20260203T171253Z
LAST-MODIFIED:20260203T213343Z
UID:3507-1770289200-1770292800@hesperosinc.com
SUMMARY:Webinar:  Multi-organ human-on-a-chip systems for predicting drug efficacy and toxicity
DESCRIPTION:James J. Hickman\, Chief Scientist at Hesperos\, will be presenting at the upcoming webinar: Multi-organ human-on-a-chip systems for predicting drug efficacy and toxicity. Explore how advanced functional human organ models improve preclinical drug testing and toxicity evaluation. \nA major challenge in drug discovery and toxicology is the gap between cell-level studies and whole-animal or human systems.  Researchers are now creating miniaturized human-on-a-chip systems where human-derived cells connect and function in ways that reflect real tissue and organ behavior\, enabling more accurate evaluation of drug efficacy and safety. \nIn this webinar\, James Hickman will discuss developing advanced multi-organ human-on-a-chip systems that model neural\, muscle\, and cardiac subsystems and how these platforms can inform preclinical decision-making. \nTopics to be covered: \n\nDesign\, fabrication\, and validation of multi-organ human-on-a-chip\nModeling motor\, cognitive\, muscle\, and cardiac functions\nApplications in preclinical drug discovery and toxicity testing\n\nClick HERE to register!
URL:https://hesperosinc.com/event/multi-organ-human-on-a-chip-systems-for-predicting-drug-efficacy-and-toxicity/
LOCATION:Virtual
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/02/DDN-webinar.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20260122
DTEND;VALUE=DATE:20260124
DTSTAMP:20260409T103734
CREATED:20260112T013437Z
LAST-MODIFIED:20260119T182021Z
UID:3463-1769040000-1769212799@hesperosinc.com
SUMMARY:International Conference on Advances in 3D Cell Culture
DESCRIPTION:Invited Speaker\nJames Hickman\, Chief Scientist\, Hesperos Inc. \nPresentation:  Regulatory acceptance of human-on-a-chip systems for efficacy and safety \nJanuary 22-23\, 2026 \nFull Program Agenda\n3DCC26_ProgramAgenda_v2 \nLink to register: https://eventregister.mumbaibiocluster.org/ \n 
URL:https://hesperosinc.com/event/international_conference_advances_3d_cell_culture/
LOCATION:Novotel Dona Sylvia Resort\, Cavelossim Road Mobor\, Cavelossim\, GA\, Goa\, India
CATEGORIES:Invited Speaker
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/01/1767447014533-e1768846809456.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20260112T080000
DTEND;TZID=UTC:20260112T170000
DTSTAMP:20260409T103734
CREATED:20260112T014558Z
LAST-MODIFIED:20260112T014558Z
UID:3477-1768204800-1768237200@hesperosinc.com
SUMMARY:2026 - MPS World Summit
DESCRIPTION:Join us! \nMore info coming soon. \nClick here to register: https://mpsworldsummit.org/2026-registration-information/
URL:https://hesperosinc.com/event/2026-mps-world-summit/
LOCATION:Walter E. Washington Convention Center
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2026/01/Screenshot-2026-01-11-184339.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251205
DTEND;VALUE=DATE:20251206
DTSTAMP:20260409T103734
CREATED:20241212T195120Z
LAST-MODIFIED:20250703T193630Z
UID:2910-1764892800-1764979199@hesperosinc.com
SUMMARY:Hybrid Public Workshop: Pediatric Developmental Safety Assessment and Novel Alternative Methods
DESCRIPTION:Hybrid Public Workshop: Pediatric Developmental Safety Assessment and Novel Alternative Methods \nDec. 5th\, 2025 \nSilver Spring\, MD \nInvited Speaker \nJ Hickman\, PhD\, Chief Scientist \nAbout the Hybrid Public Workshop: Pediatric Developmental Safety Assessment and Novel Alternative Methods:  This free public workshop is organized by the CDER Office of Clinical Pharmacology and Triangle CERSI.  It will cover advances in pediatric drug development programs and New Approach Methodologies (NAMs) being used as alternatives to animal testing in pediatric preclinical assessments.
URL:https://hesperosinc.com/event/pediatric-developmental-safety-assessment-and-novel-alternative-methods/
LOCATION:FDA White Oak Campus
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2024/12/Event-Web-Page-Graphics-49.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20251205
DTEND;VALUE=DATE:20251206
DTSTAMP:20260409T103734
CREATED:20251107T215334Z
LAST-MODIFIED:20251110T164829Z
UID:3363-1764892800-1764979199@hesperosinc.com
SUMMARY:The 3Rs Collaborative & IQ-Consortium: Microphysiological Systems Webinar & Workshop Series
DESCRIPTION:Webinar: Microphysiological Systems Webinar & Workshop Series\nWednesday\, December 3\, 2025\n10 am-12:30 p.m. (EST)\nInvited Speaker\nJ Hickman\, PhD\, Chief Scientist \n  \nAbout the webinar: 3RsC MPS in Drug Development program is an initiative by The 3Rs Collaborative (3RsC) to advance the adoption and regulatory acceptance of Microphysiological Systems (MPS) technologies\, in alignment with the principles of the 3Rs (Replacement\, Reduction\, and Refinement) in animal research. 
URL:https://hesperosinc.com/event/the-3rs-collaborative-iq-consortium-microphysiological-systems-webinar-workshop-series/
LOCATION:The Three Rs Collaborative\, United States
CATEGORIES:Invited Speaker,Webinar
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/11/Na3rc-1.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250922
DTEND;VALUE=DATE:20250926
DTSTAMP:20260409T103734
CREATED:20250609T154351Z
LAST-MODIFIED:20250610T130827Z
UID:3124-1758499200-1758844799@hesperosinc.com
SUMMARY:23rd Annual Discovery on Target
DESCRIPTION:23rd Annual Discovery on Target\nSept. 22-25 \nInvited Speaker  \nJames Hickman\, PhD\, Hesperos Co-Founder and Chief Scientist \nRegulatory Acceptance of Human-on-a-Chip Platforms \nSept. 22\, 9:00 AM EST \nAbout Discovery on Target: This week long event in Boston\, MA showcases the latest research on current and emerging drug targets and technology.  There will be numerous presentations\, discussions\, and networking opportunities for those at the forefront of drug discovery. \nLearn more and register at https://www.discoveryontarget.com/
URL:https://hesperosinc.com/event/23rd-annual-discovery-on-target/
LOCATION:Sheraton Boston
CATEGORIES:Invited Speaker
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/06/DOT-banner-LI-standard-speaking-at-code.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250917
DTEND;VALUE=DATE:20250918
DTSTAMP:20260409T103734
CREATED:20250717T181110Z
LAST-MODIFIED:20250717T181110Z
UID:3178-1758067200-1758153599@hesperosinc.com
SUMMARY:Labroots Cell Biology Virtual Events Series 2025
DESCRIPTION:Labroots Cell Biology Virtual Events Series 2025\nInvited Speaker \nChristopher Long\, PhD \nSept. 17th\, on demand all day \nAbout the Labroots Cell Biology Virtual Event Series:  This virtual event provides a place for interdisciplinary exchange and knowledge-sharing opportunities.  Leading experts\, researchers\, and innovators will share breakthroughs and discuss the latest trends and methodologies in cell biology. \nRegister free to watch Dr. Long’s presentation at https://www.labroots.com/virtual-event/cell-biology-2025
URL:https://hesperosinc.com/event/labroots-cell-biology-virtual-events-series-2025/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/07/virtual_event_header_banner_image_c1b61b6e123bfc85a6861c6cb80fc78786ff698f_5153.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250904T110000
DTEND;TZID=UTC:20250904T120000
DTSTAMP:20260409T103734
CREATED:20250829T193950Z
LAST-MODIFIED:20250829T194326Z
UID:3199-1756983600-1756987200@hesperosinc.com
SUMMARY:Webinar:  Insights Without Animals: Leveraging Human-on-a-Chip & PBPK Modeling
DESCRIPTION:Summary\nThe pharmaceutical industry is transitioning away from animal tests\, per the recent FDA Roadmap. Scientists’ need for drug development insights without animals has spurred greater interest in New Approach Methodologies (NAMs)\, such as in silico modeling and in vitro assays like organ-on-a-chip. \nThis webinar will explore how Human-on-a-Chip (HoaC) systems—combined with physiologically-based pharmacokinetic (PBPK) modeling—enable a powerful\, human-relevant approach to predicting safety and efficacy in drug development. Speakers will showcase how HoaC data can be translated into in vivo outcomes using biosimulation\, with case studies illustrating regulatory and program-level impact. \nWho should attend: \nR&D and translational leaders in biotech and pharma\nToxicologists and DMPK scientists\nClinical pharmacologists and regulatory professionals\nModeling & simulation experts \nClick here to register
URL:https://hesperosinc.com/event/webinar-insights-without-animals-leveraging-human-on-a-chip-pbpk-modeling/
LOCATION:Virtual
CATEGORIES:Webinar
ATTACH;FMTTYPE=image/png:https://hesperosinc.com/wp-content/uploads/2025/08/Screenshot-2025-08-29-134250.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250902T130000
DTEND;TZID=UTC:20250902T143000
DTSTAMP:20260409T103734
CREATED:20250829T195357Z
LAST-MODIFIED:20250829T195357Z
UID:3201-1756818000-1756823400@hesperosinc.com
SUMMARY:WC13 2025: Hesperos CEO Presents "Utilization of human on a chip systems for rare disease regulatory submissions"
DESCRIPTION:Track:  Accelerating rare disease therapeutics via adoption of human biology-based non-clinical drug development in global north and global south countries\nHuman Health – Replacement \nSession Chair \nJanette Turner – Humane World for Animals\n\nSession Speakers \n\nAbstract 553\nUtilization of human on a chip systems for rare disease regulatory submissions\nLawrence Florin\, Hesperos\, Inc.\nAbstract 323\nModelling cardiac arrhythmias with human induced pluripotent stem cells\nAntonio Carvalho\, Federal Univ. Rio de Janeiro\nAbstract 459\nMultiparametric screening of MASH clinical candidates in human liver spheroids predicts clinical outcomes and reveals potential novel combinations for anti-steatotic and anti-fibrotic therapies.\nMadhu Lal-Nag\, https://insphero.com/\nAbstract 464\nAccelerating the development of Complex In Vitro Models (CIVMs) for rare disease therapeutics in India\nFrancesca Pistollato\, Humane World for Animals Europe\n\n\nSession Description\nRare diseases represent a significant disease burden and impact up to 10% of the world’s population. In particular\, south Asian countries experience higher rates of rare genetic disorders which has been attributed to traditional marriage practices of endogamy and consanguinity. Despite this\, there are no approved treatments for almost 95% of rare diseases. While the use of genetically engineered animal models is traditionally considered as one of the main strategies for rare disease therapeutics\, these model systems have often proven unsuitable for providing human-relevant insights into the patho-mechanisms of rare diseases. Recently\, efficacy data from a microphysiological system developed using human cells were used to support the authorisation of a clinical study for chronic inflammatory demyelinating polyneuropathy\, a rare neuromuscular disease. This\, and several other examples\, highlight the potential of complex in vitro models (CIVMs)\, including induced pluripotent stem cell (iPSCs)\, organoids\, and organs-on-chips\, to provide personalized model systems for understanding the biological mechanisms and assessing drug efficacy for rare diseases. \nThis workshop will include two sessions. The first session will aim to provide a global perspective on the status quo of the use and development of complex in vitro models to support drug development of rare diseases. We will hear from experts from around the world who have successfully used CIVMs to demonstrate drug efficacy and learn more about the challenges faced across different global regions. This would include talks on successful case studies that have used CIVMs to test the efficacy of repurposed drugs and progress to clinical trials\, general overview of how industry is currently using these systems in their internal drug development pipeline for rare diseases. The session would also include two talks from global south country-perspective where the higher cost of rare disease treatments also renders it inaccessible to most of the population\, highlighting the need for his would be followed by a session where it would be discussed how these insights from rare diseases could be used to develop a generalised framework for efficacy testing for other disease categories. We hope to develop a white/status paper covering the recommendations that emerge from these sessions. \nSession organization (90 minutes) \nSession 1: Human preclinical models for rare disease therapeutics- Status quo and challenges (45 minutes)\n1. Introduction– How CIVMs can provide a personalized system for efficacy testing\, general statement of needs or challenges (Suggested Speaker: James Hickman\, Hesperos Inc. – we have reached out to Dr Hickman and he has shown interest\, yet to accept)\n2. Case study – Developing efficacy models for cystic fibrosis using lung-on-a-chip (Suggested Speaker: Roberto Plebani\, Emulate. Inc)\n3. Accelerating the development of CIVMs for rare disease therapeutics in India: Not for profit speaker (Suggested speaker: Surat Parvatam\, HSI/India) \nSession 2: Breakout session on developing a generalized framework for incorporating CIVMs for efficacy testing based on insights from rare diseases (45 minutes)\nThis breakout session will focus on discussions on how strategies and insights from efficacy modelling for rare diseases can assist in creating a generalised framework for incorporating CIVMs into efficacy modelling of other disease models.
URL:https://hesperosinc.com/event/wc13-2025-hesperos-ceo-presents-utilization-of-human-on-a-chip-systems-for-rare-disease-regulatory-submissions/
LOCATION:Riocentro Convention Center\, Av. Salvador Allende\, 6555 - Barra Olímpica\, Rio de Janeiro\, Brazil
CATEGORIES:Invited Speaker
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/08/Screenshot-2025-08-29-135151.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250817
DTEND;VALUE=DATE:20250822
DTSTAMP:20260409T103734
CREATED:20250609T164445Z
LAST-MODIFIED:20250709T180333Z
UID:3129-1755388800-1755820799@hesperosinc.com
SUMMARY:American Chemical Society (ACS) Fall 2025
DESCRIPTION:ACS Fall 2025\nAug. 17-21 \nSpeaker  \nJames Hickman\, PhD\, Hesperos Co-Founder and Chief Scientist \nAug. 19\, 11:20 AM \nHuman-on-a-chip systems for determining therapeutic index in pre-clinical drug discovery \nAbout ACS Fall 2025: Organized by the American Chemical Society\, this meeting in Washington D.C. provides an opportunity for chemistry professionals meet to share ideas and advance scientific and technical knowledge. \nLearn more and register at https://www.acs.org/events/fall.html
URL:https://hesperosinc.com/event/american-chemical-society-acs-fall-2025/
LOCATION:Walter E. Washington Convention Center
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/06/Capture.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250706
DTEND;VALUE=DATE:20250712
DTSTAMP:20260409T103734
CREATED:20250703T141436Z
LAST-MODIFIED:20250703T185309Z
UID:3168-1751760000-1752278399@hesperosinc.com
SUMMARY:2025 Drug Metabolism Gordon Research Conference
DESCRIPTION:2025 Drug Metabolism\nGordon Research Conference\nJuly 6-11 \nSpeaker  \nJames Hickman\, PhD\, Hesperos Co-Founder and Chief Scientist \nRegulatory Acceptance of Human-on-a-Chip Systems for Efficacy\, Safety\, and DMPK Studies \nJuly 8\, 9:00 AM EST \nAbout 2025 Drug Metabolism Gordon Research Conference: The Drug Metabolism GRC is a premier\, international scientific conference focused on advancing the frontiers of science through the presentation of cutting-edge and unpublished research. \nLearn more at https://www.grc.org/drug-metabolism-conference/2025/
URL:https://hesperosinc.com/event/2025-drug-metabolism-gordon-research-conference/
LOCATION:Holderness School
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/07/Event-Web-Page-Graphics-48.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250701T100000
DTEND;TZID=UTC:20250701T110000
DTSTAMP:20260409T103734
CREATED:20250630T200432Z
LAST-MODIFIED:20250630T201655Z
UID:3149-1751364000-1751367600@hesperosinc.com
SUMMARY:Animal-Free Workshop Series for Early-Career Researchers: Exploring Brain MPS\, Organoid Intelligence & Career Pathways
DESCRIPTION:Animal-Free Workshop Series for Early-Career Researchers: Exploring Brain MPS\, Organoid Intelligence & Career Pathways\nPanelist \nJames Hickman\, PhD\, Hesperos Co-Founder and Chief Scientist \nJuly 1\, 10:00 AM EST \nAbout Animal-Free Workshop Series for Early-Career Researchers: The Physician’s Committee for Responsible Medicine (PCRM) and Johns Hopkins University Center for Alternatives to Animal Testing (CAAT) host this free virtual workshop series aimed at early career researchers and focusing on animal free New Approach Methodologies (NAMs).  This workshop will feature a scientific presentation and a career panel featuring representatives from academia\, industry\, government\, and policy. \nRegister free at https://www.pcrm.org/ethical-science/ethical-education-and-training/ERA21-workshop-series
URL:https://hesperosinc.com/event/animal-free-workshop-series/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/06/Event-Web-Page-Graphics-47.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250625
DTEND;VALUE=DATE:20250626
DTSTAMP:20260409T103734
CREATED:20250424T204014Z
LAST-MODIFIED:20250424T204014Z
UID:3079-1750809600-1750895999@hesperosinc.com
SUMMARY:Replacing Animal Testing: Are In Vitro Models Ready for Prime Time?
DESCRIPTION:Replacing Animal Testing: Are In Vitro Models Ready for Prime Time? \nPanelist \nJames Hickman\, PhD\, Hesperos Co-Founder and Chief Scientist \nJune 25\, 11:00 AM EST \nAbout Replacing Animal Testing: Are In Vitro Models Ready for Prime Time?:  Organized by Biocompare\, this free virtual webinar will cover methods to reduce animal testing in drug development\, especially in light of the recent release of the FDA’s Roadmap to Reducing Animal Testing in Preclinical Safety Studies.  Attendees will hear from two expert panelists and will learn about new cutting edge technology and current capabilities. \nRegister to attend free at https://www.biocompare.com/3120-Biocompare-Webinars/618959-Replacing-Animal-Testing-Are-In-Vitro-Models-Ready-for-Prime-Time/
URL:https://hesperosinc.com/event/replacing-animal-testing-are-in-vitro-models-ready-for-prime-time/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/04/Event-Web-Page-Graphics-41.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250616
DTEND;VALUE=DATE:20250620
DTSTAMP:20260409T103734
CREATED:20250507T165402Z
LAST-MODIFIED:20250609T152229Z
UID:3090-1750032000-1750377599@hesperosinc.com
SUMMARY:BIO International Convention 2025
DESCRIPTION:BIO International Convention 2025\nWe will be a part of the Florida Pavilion at Booth #778.  Stop by and see us! \nAbout the BIO International Convention: BIO is the world’s largest advocacy association representing biotechnology companies\, academic and research institutions\, state biotechnology centers and related organizations across the United States and in more than 30 other nations.  At the BIO International Convention\, investors\, biotechs\, pharmaceutical companies\, academic institutions and non-profits gather for networking\, partnering\, and education opportunities.  This year’s convention will take place in Boston\, Massachusetts. \nLearn more and register at https://convention.bio.org/
URL:https://hesperosinc.com/event/bio-international-convention-2025/
LOCATION:Boston Convention Center
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/05/Florida-Pavillion-Social_PPT.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250609
DTEND;VALUE=DATE:20250614
DTSTAMP:20260409T103734
CREATED:20250507T163044Z
LAST-MODIFIED:20250613T143441Z
UID:3087-1749427200-1749859199@hesperosinc.com
SUMMARY:MPS World Summit 2025
DESCRIPTION:MPS World Summit 2025\nVisit us at Booth #301! \nHesperos Presenters \nJames Hickman\, PhD \nLawrence Florin \nNate Post \nRocky Brighton \nChristopher Long\, PhD \nJoseph Ciurca \nAakash Patel \nAndrew Antolic\, PhD \nBrianna Botlick \nAbout MPS World Summit 2025: MPS World Summit is a gathering organized by the International Microphysiological Systems Society (IMPSS) for leaders in the MPS field to present the latest scientific achievements\, discuss the advances and challenges\, and educate young and newly interested scientists.  The 2025 Summit will take place in Brussels\, Belgium. \nLearn more and register at https://mpsworldsummit.org/2025-registration-information/
URL:https://hesperosinc.com/event/mps-world-summit-2025/
LOCATION:Tour & Taxi
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/05/Event-Web-Page-Graphics-42.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250527T100000
DTEND;TZID=UTC:20250529T123000
DTSTAMP:20260409T103734
CREATED:20250508T135134Z
LAST-MODIFIED:20250508T161056Z
UID:3094-1748340000-1748521800@hesperosinc.com
SUMMARY:The 3Rs Collaborative Microphysiological Systems Webinar Series: Multi Organ MPS
DESCRIPTION:The 3Rs Collaborative Microphysiological Systems Webinar Series: Multi Organ MPS\nInvited Speaker \nJ Hickman\, PhD\, Chief Scientist \nMay 27th\, 10:00 am – 12:30 pm EST \nHesperos will be one of seven companies presenting on multi organ MPS on the first day. \nAbout the 3Rs Collaborative MPS Webinar Series:  Beginning December of 2021\, the 3Rs Collaborative (3RsC) and International Consortium for Innovation & Quality (IQ) Microphysiological Systems (MPS) groups worked together to establish a webinar series. This webinar series aims to facilitate communication between MPS stakeholders\, specifically technology providers and end-users.  Webinars are composed of a series of 15-minute long presentations from each company\, followed by a 30 minute long question & answer roundtable.  The 3Rs Collaborative partners with organizations across academia and industry to improve the lives of research animals by promoting the principles of Replacement\, Reduction\, and Refinement. \nRegister free to watch Dr. Hickman’s presentation at https://3rc.org/events/mps-webinars/
URL:https://hesperosinc.com/event/the-3rs-collaborative-microphysiological-systems-webinar-series-multi-organ-mps/
LOCATION:Virtual
ATTACH;FMTTYPE=image/png:https://hesperosinc.com/wp-content/uploads/2025/05/Na3rc-6.png
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250520T150000
DTEND;TZID=UTC:20250520T160000
DTSTAMP:20260409T103734
CREATED:20250508T160826Z
LAST-MODIFIED:20250521T134622Z
UID:3096-1747753200-1747756800@hesperosinc.com
SUMMARY:Frontiers in Cardiovascular Science Symposium
DESCRIPTION:Frontiers in Cardiovascular Science Symposium\nInvited Speaker \nJ Hickman\, PhD\, Chief Scientist \nMay 20th\, 12:00 pm – 1:00 pm PST\, 3:00-4:00 pm EST \nMulti-Organ Platforms Containing Human Cardiac\, Neuronal\, Liver and Other Organ Mimics for Efficacy and Safety Evaluation of Therapeutics \nAbout Frontiers in Cardiovascular Science Symposium:  Frontiers in Cardiovascular Science is a weekly symposium held at Stanford Cardiovascular Institute.  It features a different speaker each week and focuses on new advancements in the field.  It is also available for virtual participation. \nRegister free to watch Dr. Hickman’s presentation at https://stanford.zoom.us/webinar/register/WN_6UNBzPNdRKmaJ8zXuIdLYQ#/registration
URL:https://hesperosinc.com/event/frontiers-in-cardiovascular-science-symposium/
LOCATION:Virtual\, Stanford Biomedical Innovations
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/05/Event-Web-Page-Graphics-44.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250423T110000
DTEND;TZID=UTC:20250424T150000
DTSTAMP:20260409T103734
CREATED:20250218T151851Z
LAST-MODIFIED:20250421T143246Z
UID:3021-1745406000-1745506800@hesperosinc.com
SUMMARY:Innovations in Disease Modeling 2025
DESCRIPTION:Innovations in Disease Modeling 2025 \nKeynote Speaker \nMichael Shuler\, PhD\, Hesperos President \nBuilding and Using “Body-on-a-Chip” in Preclinical Drug Development \nApril 23\, 11:00 AM – 12:00 PM EST \nAbout Innovations in Disease Modeling 2025:  Organized by Technology Networks\, this free virtual event highlights advances in in vitro and in vivo models in biomedical research.  Attendees will learn about advances in AI\, mathematical models\, and in vivo and in vitro models. \nRegister to attend free at https://www.technologynetworks.com/drug-discovery/online-events/innovations-in-disease-modeling-2025-395497
URL:https://hesperosinc.com/event/innovations-in-disease-modeling/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/02/Event-Web-Page-Graphics-37.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250405
DTEND;VALUE=DATE:20250410
DTSTAMP:20260409T103734
CREATED:20250204T201839Z
LAST-MODIFIED:20250421T184611Z
UID:2983-1743811200-1744243199@hesperosinc.com
SUMMARY:American Academy of Neurology 2025 Annual Meeting
DESCRIPTION:American Academy of Neurology 2025 Annual Meeting \nApril 5-9\, 2025 \nSan Diego\, CA \nPoster Presentation \nKaveena Autar\, PhD \nPoster #015 \n“The Utilization of In Vitro Human-on-a-Chip Neural Networks to Assess Neurocognitive Impairment for Drug Safety and Efficacy” \nP5: Aging\, Dementia\, and Behavioral Neurology: AI and Basic Science in Behavioral Neurology \nMonday\, April 7\, from 8:00 AM–9:00 AM PST \nAbout AAN 2025 Annual Meeting:  The American Academy of Neurology’s Annual Meeting brings together thousands of neuroscientists to discuss scientific discoveries\, educate one another\, and network with other professionals from around the world. \n Poster presentations from the AAN 2025 Annual Meeting will also be available for viewing online during the specified presentation times.  Learn more and register at https://www.aan.com/msa/Public/Events/AbstractDetails/60423 \nMake sure to stop by and see Dr. Autar if you’re there!
URL:https://hesperosinc.com/event/american-academy-of-neurology-2025/
LOCATION:San Diego Convention Center
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/02/Event-Web-Page-Graphics-38.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250329
DTEND;VALUE=DATE:20250401
DTSTAMP:20260409T103734
CREATED:20250205T144954Z
LAST-MODIFIED:20250205T144954Z
UID:2994-1743206400-1743465599@hesperosinc.com
SUMMARY:American College of Cardiology 25
DESCRIPTION:American College of Cardiology 25 \nMarch 29-31\, 2025 \nChicago\, IL \nAbout ACC.25:  Hosted by the American College of Cardiology in Chicago\, this meeting will provide experts in the field of cardiology with the opportunity to engage with peers from around the world and hear the latest updates in the field.  ACC.25 will feature educational sessions on groundbreaking clinical research.  It will be a key forum for networking with other professionals. \nLearn more and register at https://accscientificsession.acc.org
URL:https://hesperosinc.com/event/american-college-of-cardiology-25/
LOCATION:McCormick Place Convention Center
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/02/Event-Web-Page-Graphics-27.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250316T121500
DTEND;TZID=UTC:20250316T164500
DTSTAMP:20260409T103734
CREATED:20250122T191651Z
LAST-MODIFIED:20250312T201648Z
UID:2954-1742127300-1742143500@hesperosinc.com
SUMMARY:Hesperos Technology for Toxicology Research: From Development to Approval Workshop and Expert Panel
DESCRIPTION:Hesperos Technology for Toxicology Research: From Development to Approval \nWorkshop and Expert Panel \nMarch 16th\, 12:15-4:45 pm \nAbout Hesperos Technology for Toxicology Research: From Development to Approval:  Put on by the Physician’s Committee for Responsible Medicine (PCRM)\, the Johns Hopkins Center for Alternatives to Animal Testing\, and Hesperos Inc.\, this workshop and expert panel is an opportunity for interested researchers to tour Hesperos’s facility and learn about our cutting edge Human-On-A-Chip® technology.  Thomas Hartung\, Elizabeth Baker\, and J. Hickman will serve as the expert panel\, discussing the state of the field\, clinical and regulatory acceptance\, and technological advances. \nRegistration is required to attend and is limited to 20 people.  Learn more at https://forms.office.com/pages/responsepage.aspx? \n 
URL:https://hesperosinc.com/event/hesperos-technology-workshop-and-expert-panel/
LOCATION:Hesperos Inc.\, 12501 Research Pkwy\, Orlando\, FL\, 32826\, United States
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/01/25022-RAD-Hesperos-Event-LinkedIn-Graphic.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20250316
DTEND;VALUE=DATE:20250321
DTSTAMP:20260409T103734
CREATED:20250124T184351Z
LAST-MODIFIED:20250317T203147Z
UID:2965-1742083200-1742515199@hesperosinc.com
SUMMARY:2025 Annual SOT Meeting and ToxExpo
DESCRIPTION:2025 Annual SOT Meeting and ToxExpo \nMarch 16-20\, 2025 \nOrlando\, FL \nHesperos Panel Chair \nJ. Hickman\, PhD\, co-chair \nNext generation of in vitro neurotoxicology – modeling cognition-in-a-dish \nMarch 19\, 8:00 am \nHesperos at SOT 2025 \nVisit us at Booth #1071 in the ToxExpo Hall! \nHesperos Posters \nJ. Hickman\, PhD: #L609 \nDifferential Metabolism in Microphysiological Systems for Evaluation of Efficacy and Off-target Toxicity for the NK-1 Antagonist Tradipitant \nMarch 19\, 9:15-11:45 am \nKaveena Autar\, PhD: #P745 \nThe Utilization of In Vitro\, Human-on-a-Chip® Cortical Networks to Assess Neurocognitive Impairment for Drug Safety and Efficacy \nMarch 18\, 9:15-11:45 am \nMridu Malik\, PhD:#K569 \nOff-target toxicity and efficacy testing of a novel stress reliever in a multi-organ microphysiological system \nMarch 19\, 9:15-11:45 am \nWalker Hagan\, PhD: #K571 \nA Human-on-a-Chip® neuromuscular junction model for the evaluation of botulinum neurotoxin potency \nMarch 19\, 9:15-11:45 am \nMichael Jakob Rupar: #K565 \nSafety Assessment of Antimalarial Therapeutic Delivery in a Human-Based Malaria-on-a-Chip® Phenotypic Disease Model \nMarch 19\, 9:15-11:45 am \nAbout the 2025 Annual SOT Meeting and ToxExpo: Hosted by the Society of Toxicology at the Orange County Convention Center in Orlando\, this event brings together experts in the field of toxicology for five days of scientific sessions\, poster presentations\, and networking events. \nLearn more and register at: https://www.toxicology.org/events/am/AM2025/index.asp#
URL:https://hesperosinc.com/event/2025-annual-sot-meeting-and-toxexpo/
LOCATION:Orange County Convention Center
CATEGORIES:Exhibitor,Poster Presentation
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/01/SOT-social.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250227T100000
DTEND;TZID=UTC:20250228T160000
DTSTAMP:20260409T103734
CREATED:20250218T150444Z
LAST-MODIFIED:20250218T150444Z
UID:2980-1740650400-1740758400@hesperosinc.com
SUMMARY:FDA-NIH Rare Disease Day 2025
DESCRIPTION:FDA-NIH Rare Disease Day 2025 \nFeb. 27-28\, 2025 \nBethesda\, MD \nPoster Presentation \nKaveena Autar\, PhD \nAbout Rare Disease Day:  Rare Disease Day is a day to raise awareness among both lawmakers and the general public about rare diseases and their impacts on patients’ lives.  NIH/NCATS and the FDA are sponsoring a shared Rare Disease Day event this year.  They are aiming to inform patients\, researchers\, caretakers\, and advocacy groups about the latest research for this underserved population. \nThis is a free event open to the public. Learn more and register at https://ncats.nih.gov/news-events/events/rddhttps://www.gsa2024.org/ \nMake sure to stop by and see Dr. Autar if you’re there!
URL:https://hesperosinc.com/event/fda-nih-rare-disease-day-2025/
LOCATION:NIH Main Campus
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250131T160000
DTEND;TZID=UTC:20250131T170000
DTSTAMP:20260409T103734
CREATED:20250117T172840Z
LAST-MODIFIED:20250117T172840Z
UID:2923-1738339200-1738342800@hesperosinc.com
SUMMARY:Ask Me Anything: Body-on-a-Chip
DESCRIPTION:Ask Me Anything: Body-on-a-Chip \nInvited Speaker \nMichael Shuler\, PhD\, Hesperos President \nJan. 31st\, 4:00 pm GMT/11:00 AM EST \nAbout the Ask Me Anything: Body-on-a-Chip:  Organized by Technology Networks\, this is an open session for a live audience to ask Dr. Shuler anything about microfluidic devices and his work in the MPS field. \nRegister to attend or watch virtually free at https://www.technologynetworks.com/tn/ask-me-anythings/ask-me-anything-body-on-a-chip-373531
URL:https://hesperosinc.com/event/ask-me-anything-body-on-a-chip/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2025/01/Event-Web-Page-Graphics-25.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241217
DTEND;VALUE=DATE:20241219
DTSTAMP:20260409T103734
CREATED:20241212T191619Z
LAST-MODIFIED:20241216T144658Z
UID:2899-1734393600-1734566399@hesperosinc.com
SUMMARY:Advances in Developing Medical Countermeasures Against Opioids and Drug-Induced Respiratory Depression Meeting
DESCRIPTION:Advances in Developing Medical Countermeasures Against Opioids and Drug-Induced Respiratory Depression Meeting \nInvited Speaker \nJ Hickman\, PhD\, Chief Scientist \n“Multi-organ human-on-a-chip system to address overdose and recovery for efficacy and off-target toxicity for evaluations of therapeutics”\nSession 3: Drug Development Tools and Models\, Dec. 18th\, 9:40 am \nAbout the 2024 NIAID Advances in Developing Medical Countermeasures Against Opioids and Drug-Induced Respiratory Depression:  Sponsored by the NIH\, NIAID\, and BARDA\, this meeting will gather leaders in academia\, industry\, and government to discuss the latest research on opioid and other drug-induced toxicities.  They will also address knowledge gaps on changes that occur following acute exposure to opioids\, and discuss the current state of the field. \nLearn more at https://web.cvent.com/event/0e39e595-3a25-4445-bf9d-7318d6482996/summary
URL:https://hesperosinc.com/event/2024-niaid-advances-in-developing-medical-countermeasures/
LOCATION:NIAID Conference Center\, 5601 Fishers Lane\, Rockville\, MD\, 20852
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2024/12/Event-Web-Page-Graphics-23.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20241204T100000
DTEND;TZID=UTC:20241204T130000
DTSTAMP:20260409T103734
CREATED:20241105T151428Z
LAST-MODIFIED:20241212T170908Z
UID:2806-1733306400-1733317200@hesperosinc.com
SUMMARY:The 3Rs Collaborative Microphysiological Systems Webinar Series: Oncology MPS
DESCRIPTION:The 3Rs Collaborative Microphysiological Systems Webinar Series: Oncology MPS \nInvited Speaker \nJ Hickman\, PhD\, Chief Scientist \nDec. 4th\, 10:00 am – 1:00 pm EST \n“Hesperos will be one of nine companies presenting on oncology MPS.” \nAbout the 3Rs Collaborative MPS Webinar Series:  Beginning December of 2021\, the 3Rs Collaborative (3RsC) and International Consortium for Innovation & Quality (IQ) Microphysiological Systems (MPS) groups worked together to establish a webinar series. This webinar series aims to facilitate communication between MPS stakeholders\, specifically technology providers and end-users.  Webinars are composed of a series of 15-minute long presentations from each company\, followed by a 30 minute long question & answer roundtable.  The 3Rs Collaborative partners with organizations across academia and industry to improve the lives of research animals by promoting the principles of Replacement\, Reduction\, and Refinement. \nRegister free to watch Dr. Hickman’s presentation at https://3rc.org/events/mps-webinars/ \n\n\n\n\n\n\n 
URL:https://hesperosinc.com/event/the-3rs-collaborative-microphysiological-systems-webinar-series-oncology-mps/
LOCATION:Virtual
CATEGORIES:Invited Speaker
ATTACH;FMTTYPE=image/png:https://hesperosinc.com/wp-content/uploads/2024/11/Na3rc-5.png
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241118
DTEND;VALUE=DATE:20241121
DTSTAMP:20260409T103734
CREATED:20241030T140650Z
LAST-MODIFIED:20241114T172742Z
UID:2782-1731888000-1732147199@hesperosinc.com
SUMMARY:Florida Innovation Conference\, powered by BioFlorida
DESCRIPTION:Florida Innovation Conference \nInvited Speaker \nJ. Hickman\, PhD\, Chief Scientist \nTrack A: Growth Company Spotlights | Biotechnology and Pharmaceuticals \nNov. 19\, 10:45-11:45 am EST \nHesperos at the Florida Innovation Conference \nWe will be at Booth #27.  Stop by and see us! \nAbout the Florida Innovation Conference: The Florida Innovation Conference\, organized by BioFlorida\, brings researchers\, entrepreneurs\, executives\, and policymakers together to discuss the latest news in the life sciences industry and to strategize on Florida’s life sciences industry path forward.  BioFlorida is the voice of Florida’s life sciences industry\, representing 8\,600 establishments and research organizations in the BioPharma\, MedTech\, Digital Health and Health Systems that collectively employ nearly 107\,000 Floridians.  This year’s meeting will be held in Orlando\, FL\, Nov 18-20. \nLearn more and register at https://www.bioflorida.com/page/About2024
URL:https://hesperosinc.com/event/florida-innovation-conference-powered-by-bioflorida/
LOCATION:Walt Disney World Swan\, Orlando\, FL\, United States
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2024/10/Event-Web-Page-Graphics-17.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20241118
DTEND;VALUE=DATE:20241120
DTSTAMP:20260409T103734
CREATED:20241105T151450Z
LAST-MODIFIED:20241115T150421Z
UID:2798-1731888000-1732060799@hesperosinc.com
SUMMARY:World Pharma 2024
DESCRIPTION:World Pharma 2024 \nInvited Speaker \nJ Hickman\, PhD\, Chief Scientist \n“Human-on-a-chip systems as pre-clinical models for neurological diseases and disorders” \nNov. 19\, 11:10 am EST \nAbout World Pharma 2024:  World Pharma 2024 is a virtual gathering for the health industry professionals worldwide.  Directors\, scientists\, professors\, and research scholars are invited to share their research and discuss emerging technological trends in the pharmaceutical industry. This an international platform to share knowledge and learn about new discoveries in the area of drug development.  This year’s virtual meeting is Nov 18-19\, 2024. \nLearn more and register at https://pharmaconference.pagicle.com/
URL:https://hesperosinc.com/event/world-pharma-2024/
LOCATION:Virtual
ATTACH;FMTTYPE=image/jpeg:https://hesperosinc.com/wp-content/uploads/2024/11/Event-Web-Page-Graphics-18.jpg
END:VEVENT
END:VCALENDAR